Abstract
Nanotechnology is a rapid-growing field with an extreme potential to revolutionize cancer treatments. However, despite the rapid advances, the clinical translation is still scarce. One of the main hurdles contributing for this setback is the lack of reliable in vitro models for preclinical testing capable of predicting the outcomes in an in vivo setting. In fact, the use of 2D monolayers, considered the gold-standard in vitro technique, leads to the creation of misleading data that might not be completely observed in in vivo or clinical setting. Thus, there is the need to use more complex models capable of better mimicking the tumor microenvironment. For that purpose, the development and use of multicellular tumor spheroids, three-dimensional (3D) cell cultures which recapitulate numerous aspects of the tumors, represents an advantageous approach to test the developed anticancer therapies. In this chapter, we identify and discuss the advantages of the use of these 3D cellular models compared to the 2D models and how they can be utilized to study nanoparticle-cancer cell interaction in a more reliable way to predict the treatment outcome in vivo.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 68(6), 394–424.
Brannon-Peppas, L., & Blanchette, J. O. (2004). Nanoparticle and targeted systems for cancer therapy. Advanced Drug Delivery Reviews, 56(11), 1649–1659.
Chakraborty, S., & Rahman, T. (2012). The difficulties in cancer treatment. Ecancermedicalscience, 6, ed16.
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017). Cancer nanomedicine: Progress, challenges and opportunities. Nature Reviews. Cancer, 17(1), 20–37.
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007). Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnology, 2(12), 751–760.
van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F., Mulder, W. J. M., & Lammers, T. (2019). Smart cancer nanomedicine. Nature Nanotechnology, 14(11), 1007–1017.
Figueiredo, P., Bauleth-Ramos, T., Hirvonen, J., Sarmento, B., & Santos, H. A. (2018). Chapter 1 – The emerging role of multifunctional theranostic materials in cancer nanomedicine. In J. Conde (Ed.), Handbook of nanomaterials for cancer theranostics (pp. 1–31). Elsevier: Amsterdam, The Netherlands.
Balasubramanian, V., Liu, Z., Hirvonen, J., & Santos, H. A. (2018). Bridging the knowledge of different worlds to understand the big picture of cancer nanomedicines. Advanced Healthcare Materials, 7(1), 1700432.
Hare, J. I., Lammers, T., Ashford, M. B., Puri, S., Storm, G., & Barry, S. T. (2017). Challenges and strategies in anti-cancer nanomedicine development: An industry perspective. Advanced Drug Delivery Reviews, 108, 25–38.
Shreffler, J. W., Pullan, J. E., Dailey, K. M., Mallik, S., & Brooks, A. E. (2019). Overcoming hurdles in nanoparticle clinical translation: The influence of experimental design and surface modification. International Journal of Molecular Sciences, 20(23), 6056.
Choi, S. Y., Lin, D., Gout, P. W., Collins, C. C., Xu, Y., & Wang, Y. (2014). Lessons from patient-derived xenografts for better in vitro modeling of human cancer. Advanced Drug Delivery Reviews, 79–80, 222–237.
Thoma, C. R., Zimmermann, M., Agarkova, I., Kelm, J. M., & Krek, W. (2014). 3D cell culture systems modeling tumor growth determinants in cancer target discovery. Advanced Drug Delivery Reviews, 69–70, 29–41.
Chatzinikolaidou, M. (2016). Cell spheroids: The new frontiers in in vitro models for cancer drug validation. Drug Discovery Today, 21(9), 1553–1560.
Niu, N., & Wang, L. (2015). In vitro human cell line models to predict clinical response to anticancer drugs. Pharmacogenomics, 16(3), 273–285.
Nunes, A. S., Barros, A. S., Costa, E. C., Moreira, A. F., & Correia, I. J. (2019). 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnology and Bioengineering, 116(1), 206–226.
Ibarrola-Villava, M., Cervantes, A., & Bardelli, A. (2018). Preclinical models for precision oncology. Biochimica Et Biophysica Acta. Reviews on Cancer, 1870(2), 239–246.
Cifola, I., Bianchi, C., Mangano, E., Bombelli, S., Frascati, F., Fasoli, E., Ferrero, S., Di Stefano, V., Zipeto, M. A., Magni, F., Signorini, S., Battaglia, C., & Perego, R. A. (2011). Renal cell carcinoma primary cultures maintain genomic and phenotypic profile of parental tumor tissues. BMC Cancer, 11, 244.
Fabbrizi Maria, R., Duff, T., Oliver, J., & Wilde, C. (2014). Advanced in vitro systems for efficacy and toxicity testing in nanomedicine. European Journal of Nanomedicine, 6, 171.
Weiswald, L. B., Bellet, D., & Dangles-Marie, V. (2015). Spherical cancer models in tumor biology. Neoplasia, 17(1), 1–15.
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007). The third dimension bridges the gap between cell culture and live tissue. Nature Reviews Molecular Cell Biology, 8(10), 839–845.
Xu, X., Farach-Carson, M. C., & Jia, X. (2014). Three-dimensional in vitro tumor models for cancer research and drug evaluation. Biotechnology Advances, 32(7), 1256–1268.
Klimkiewicz, K., Weglarczyk, K., Collet, G., Paprocka, M., Guichard, A., Sarna, M., Jozkowicz, A., Dulak, J., Sarna, T., Grillon, C., & Kieda, C. (2017). A 3D model of tumour angiogenic microenvironment to monitor hypoxia effects on cell interactions and cancer stem cell selection. Cancer Letters, 396, 10–20.
Baker, B. M., & Chen, C. S. (2012). Deconstructing the third dimension – how 3D culture microenvironments alter cellular cues. Journal of Cell Science, 125(13), 3015–3024.
Lamichhane, S. P., Arya, N., Kohler, E., Xiang, S., Christensen, J., & Shastri, V. P. (2016). Recapitulating epithelial tumor microenvironment in vitro using three dimensional tri-culture of human epithelial, endothelial, and mesenchymal cells. BMC Cancer, 16(1), 581.
Cavo, M., Fato, M., Peñuela, L., Beltrame, F., Raiteri, R., & Scaglione, S. (2016). Microenvironment complexity and matrix stiffness regulate breast cancer cell activity in a 3D in vitro model. Scientific Reports, 6, 35367.
Liu, T., Lin, B., & Qin, J. (2010). Carcinoma-associated fibroblasts promoted tumor spheroid invasion on a microfluidic 3D co-culture device. Lab on a Chip, 10(13), 1671–1677.
Shoval, H., Karsch-Bluman, A., Brill-Karniely, Y., Stern, T., Zamir, G., Hubert, A., & Benny, O. (2017). Tumor cells and their crosstalk with endothelial cells in 3D spheroids. Scientific Reports, 7(1), 10428.
Hirschhaeuser, F., Menne, H., Dittfeld, C., West, J., Mueller-Klieser, W., & Kunz-Schughart, L. A. (2010). Multicellular tumor spheroids: An underestimated tool is catching up again. Journal of Biotechnology, 148(1), 3–15.
Haycock, J. W. (2011). 3D Cell culture: A review of current approaches and techniques. In J. W. Haycock (Ed.), 3D cell culture: Methods and protocols (pp. 1–15). Totowa: Humana Press.
Hutmacher, D. W., Horch, R. E., Loessner, D., Rizzi, S., Sieh, S., Reichert, J. C., Clements, J. A., Beier, J. P., Arkudas, A., Bleiziffer, O., & Kneser, U. (2009). Translating tissue engineering technology platforms into cancer research. Journal of Cellular and Molecular Medicine, 13(8a), 1417–1427.
Knight, E., & Przyborski, S. (2015). Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro. Journal of Anatomy, 227(6), 746–756.
Kunz-Schughart, L. A. (1999). Multicellular tumor spheroids: Intermediates between monolayer culture and in vivo tumor. Cell Biology International, 23(3), 157–161.
Huang, B.-W., & Gao, J.-Q. (2018). Application of 3D cultured multicellular spheroid tumor models in tumor-targeted drug delivery system research. Journal of Controlled Release, 270, 246–259.
Froehlich, K., Haeger, J.-D., Heger, J., Pastuschek, J., Photini, S. M., Yan, Y., Lupp, A., Pfarrer, C., Mrowka, R., Schleußner, E., Markert, U. R., & Schmidt, A. (2016). Generation of multicellular breast cancer tumor spheroids: Comparison of different protocols. Journal of Mammary Gland Biology and Neoplasia, 21(3), 89–98.
Achilli, T.-M., Meyer, J., & Morgan, J. R. (2012). Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opinion on Biological Therapy, 12(10), 1347–1360.
Tung, Y.-C., Hsiao, A. Y., Allen, S. G., Torisawa, Y.-S., Ho, M., & Takayama, S. (2011). High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst, 136(3), 473–478.
Timmins, N. E., & Nielsen, L. K. (2007). Generation of multicellular tumor spheroids by the hanging-drop method. In H. Hauser & M. Fussenegger (Eds.), Tissue engineering (pp. 141–151). Totowa: Humana Press.
Sutherland, R. M., McCredie, J. A., & Inch, W. R. (1971). Growth of multicell spheroids in tissue culture as a model of nodular carcinomas. JNCI: Journal of the National Cancer Institute, 46(1), 113–120.
Tang, Y., Liu, J., & Chen, Y. (2016). Agarose multi-wells for tumour spheroid formation and anti-cancer drug test. Microelectronic Engineering, 158, 41–45.
Costa, E. C., de Melo-Diogo, D., Moreira, A. F., Carvalho, M. P., & Correia, I. J. (2018). Spheroids formation on non-adhesive surfaces by liquid overlay technique: Considerations and practical approaches. Biotechnology Journal, 13(1), 1700417.
Mehta, G., Hsiao, A. Y., Ingram, M., Luker, G. D., & Takayama, S. (2012). Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy. Journal of Controlled Release, 164(2), 192–204.
Lu, H., & Stenzel, M. H. (2018). Multicellular tumor spheroids (MCTS) as a 3D in vitro evaluation tool of nanoparticles. Small, 14(13), 1702858.
Gebhard, C., Gabriel, C., & Walter, I. (2016). Morphological and immunohistochemical characterization of canine osteosarcoma spheroid cell cultures. Anatomia, Histologia, Embryologia, 45(3), 219–230.
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R. (2004). The use of 3-D cultures for high-throughput screening: The multicellular spheroid model. Journal of Biomolecular Screening, 9(4), 273–285.
Lin, R.-Z., & Chang, H.-Y. (2008). Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnology Journal, 3(9–10), 1172–1184.
Katt, M. E., Placone, A. L., Wong, A. D., Xu, Z. S., & Searson, P. C. (2016). In vitro tumor models: Advantages, disadvantages, variables, and selecting the right platform. Frontiers in Bioengineering and Biotechnology, 4, 12.
Rohwer, N., & Cramer, T. (2011). Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways. Drug Resistance Updates, 14(3), 191–201.
Trédan, O., Galmarini, C. M., Patel, K., & Tannock, I. F. (2007). Drug resistance and the solid tumor microenvironment. JNCI: Journal of the National Cancer Institute, 99(19), 1441–1454.
Swietach, P., Hulikova, A., Patiar, S., Vaughan-Jones, R. D., & Harris, A. L. (2012). Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin. PloS One, 7(4), e35949.
Majety, M., Pradel, L. P., Gies, M., & Ries, C. H. (2015). Fibroblasts influence survival and therapeutic response in a 3D co-culture model. PLoS One, 10(6), e0127948.
Lee, J. W., Shin, D. H., & Roh, J. L. (2018). Development of an in vitro cell-sheet cancer model for chemotherapeutic screening. Theranostics, 8(14), 3964–3973.
Correia, A. L., & Bissell, M. J. (2012). The tumor microenvironment is a dominant force in multidrug resistance. Drug Resistance Updates, 15(1), 39–49.
Sun, Y. (2016). Tumor microenvironment and cancer therapy resistance. Cancer Letters, 380(1), 205–215.
Pickup, M. W., Mouw, J. K., & Weaver, V. M. (2014). The extracellular matrix modulates the hallmarks of cancer. EMBO Reports, 15(12), 1243–1253.
Costa, E. C., Moreira, A. F., de Melo-Diogo, D., Gaspar, V. M., Carvalho, M. P., & Correia, I. J. (2016). 3D tumor spheroids: An overview on the tools and techniques used for their analysis. Biotechnology Advances, 34(8), 1427–1441.
Longati, P., Jia, X., Eimer, J., Wagman, A., Witt, M.-R., Rehnmark, S., Verbeke, C., Toftgård, R., Löhr, M., & Heuchel, R. L. (2013). 3D pancreatic carcinoma spheroids induce a matrix-rich, chemoresistant phenotype offering a better model for drug testing. BMC Cancer, 13(1), 95.
Nath, S., & Devi, G. R. (2016). Three-dimensional culture systems in cancer research: Focus on tumor spheroid model. Pharmacology and Therapeutics, 163, 94–108.
Ma, H.-L., Jiang, Q., Han, S., Wu, Y., Tomshine, J. C., Wang, D., Gan, Y., Zou, G., & Liang, X.-J. (2012). Multicellular tumor spheroids as an in vivo–like tumor model for three-dimensional imaging of chemotherapeutic and nano material cellular penetration. Molecular Imaging, 11(6), 7290.2012.00012.
Zanoni, M., Piccinini, F., Arienti, C., Zamagni, A., Santi, S., Polico, R., Bevilacqua, A., & Tesei, A. (2016). 3D tumor spheroid models for in vitro therapeutic screening: A systematic approach to enhance the biological relevance of data obtained. Scientific Reports, 6, 19103.
Fang, Y., & Eglen, R. M. (2017). Three-dimensional cell cultures in drug discovery and development. Slas Discovery: Advancing Life Sciences R&D, 22(5), 456–472.
Rodrigues, T., Kundu, B., Silva-Correia, J., Kundu, S. C., Oliveira, J. M., Reis, R. L., & Correlo, V. M. (2018). Emerging tumor spheroids technologies for 3D in vitro cancer modeling. Pharmacology and Therapeutics, 184, 201–211.
Hoarau-Véchot, J., Rafii, A., Touboul, C., & Pasquier, J. (2018). Halfway between 2D and animal models: Are 3D cultures the ideal tool to study cancer-microenvironment interactions? International Journal of Molecular Sciences, 19(1), 181.
Li, Y., Wang, J., Wientjes, M. G., & Au, J. L. S. (2012). Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor. Advanced Drug Delivery Reviews, 64(1), 29–39.
Ozcelikkale, A., Ghosh, S., & Han, B. (2013). Multifaceted transport characteristics of nanomedicine: Needs for characterization in dynamic environment. Molecular Pharmaceutics, 10(6), 2111–2126.
Shi, W. B., Le, V. M., Gu, C. H., Zheng, Y. H., Lang, M. D., Lu, Y. H., & Liu, J. W. (2014). Overcoming multidrug resistance in 2D and 3D culture models by controlled drug chitosan‐graft poly(caprolactone)‐based nanoparticles. Journal of Pharmaceutical Sciences, 103(4), 1064–1074.
Biondi, M., Guarnieri, D., Yu, H., Belli, V., & Netti, P. A. (2013). Sub-100 nm biodegradable nanoparticles: In vitro release features and toxicity testing in 2D and 3D cell cultures. Nanotechnology, 24(4), 045101.
Solomon, M. A., Lemera, J., & D’Souza, G. G. M. (2016). Development of an in vitro tumor spheroid culture model amenable to high-throughput testing of potential anticancer nanotherapeutics. Journal of Liposome Research, 26(3), 246–260.
Millard, M., Yakavets, I., Zorin, V., Kulmukhamedova, A., Marchal, S., & Bezdetnaya, L. (2017). Drug delivery to solid tumors: The predictive value of the multicellular tumor spheroid model for nanomedicine screening. International Journal of Nanomedicine, 12, 7993–8007.
Tchoryk, A., Taresco, V., Argent, R. H., Ashford, M., Gellert, P. R., Stolnik, S., Grabowska, A., & Garnett, M. C. (2019). Penetration and uptake of nanoparticles in 3D tumor spheroids. Bioconjugate Chemistry, 30(5), 1371–1384.
Durymanov, M., Kroll, C., Permyakova, A., & Reineke, J. (2019). Role of endocytosis in nanoparticle penetration of 3D pancreatic cancer spheroids. Molecular Pharmaceutics, 16(3), 1074–1082.
Huo, S., Ma, H., Huang, K., Liu, J., Wei, T., Jin, S., Zhang, J., He, S., & Liang, X. J. (2013). Superior penetration and retention behavior of 50 nm gold nanoparticles in tumors. Cancer Research, 73(1), 319–330.
Huang, K., Ma, H., Liu, J., Huo, S., Kumar, A., Wei, T., Zhang, X., Jin, S., Gan, Y., Wang, P. C., He, S., Zhang, X., & Liang, X. J. (2012). Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano, 6(5), 4483–4493.
Albanese, A., Lam, A. K., Sykes, E. A., Rocheleau, J. V., & Chan, W. C. W. (2013). Tumour-on-a-chip provides an optical window into nanoparticle tissue transport. Nature Communications, 4(1), 2718.
Tang, L., Yang, X., Yin, Q., Cai, K., Wang, H., Chaudhury, I., Yao, C., Zhou, Q., Kwon, M., Hartman, J. A., Dobrucki, I. T., Dobrucki, L. W., Borst, L. B., Lezmi, S., Helferich, W. G., Ferguson, A. L., Fan, T. M., & Cheng, J. (2014). Investigating the optimal size of anticancer nanomedicine. Proceedings of the National Academy of Sciences, 111(43), 15344–15349.
Stylianopoulos, T., Poh, M.-Z., Insin, N., Bawendi, M. G., Fukumura, D., Munn, L. L., & Jain, R. K. (2010). Diffusion of particles in the extracellular matrix: The effect of repulsive electrostatic interactions. Biophysical Journal, 99(5), 1342–1349.
Suzuki, S., Itakura, S., Matsui, R., Nakayama, K., Nishi, T., Nishimoto, A., Hama, S., & Kogure, K. (2017). Tumor microenvironment-sensitive liposomes penetrate tumor tissue via attenuated interaction of the extracellular matrix and tumor cells and accompanying actin depolymerization. Biomacromolecules, 18(2), 535–543.
Jin, S., Ma, X., Ma, H., Zheng, K., Liu, J., Hou, S., Meng, J., Wang, P. C., Wu, X., & Liang, X. J. (2013). Surface chemistry-mediated penetration and gold nanorod thermotherapy in multicellular tumor spheroids. Nanoscale, 5(1), 143–146.
Lieleg, O., Baumgartel, R. M., & Bausch, A. R. (2009). Selective filtering of particles by the extracellular matrix: An electrostatic bandpass. Biophysical Journal, 97(6), 1569–1577.
Kostarelos, K., Emfietzoglou, D., Papakostas, A., Yang, W.-H., Ballangrud, Å., & Sgouros, G. (2004). Binding and interstitial penetration of liposomes within avascular tumor spheroids. International Journal of Cancer, 112(4), 713–721.
Ernsting, M. J., Murakami, M., Roy, A., & Li, S. D. (2013). Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles. Journal of Controlled Release, 172(3), 782–794.
Dias, D. R., Moreira, A. F., & Correia, I. J. (2016). The effect of the shape of gold core–mesoporous silica shell nanoparticles on the cellular behavior and tumor spheroid penetration. Journal of Materials Chemistry B, 4(47), 7630–7640.
Agarwal, R., Jurney, P., Raythatha, M., Singh, V., Sreenivasan, S. V., Shi, L., & Roy, K. (2015). Effect of shape, size, and aspect ratio on nanoparticle penetration and distribution inside solid tissues using 3D spheroid models. Advanced Healthcare Materials, 4(15), 2269–2280.
Wang, W., Gaus, K., Tilley, R. D., & Gooding, J. J. (2019). The impact of nanoparticle shape on cellular internalisation and transport: What do the different analysis methods tell us? Materials Horizons, 6(8), 1538–1547.
Lee, K. L., Hubbard, L. C., Hern, S., Yildiz, I., Gratzl, M., & Steinmetz, N. F. (2013). Shape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinct. Biomaterials Science, 1(6), 581–588.
Chauhan, V. P., Popović, Z., Chen, O., Cui, J., Fukumura, D., Bawendi, M. G., & Jain, R. K. (2011). Fluorescent nanorods and nanospheres for real-time in vivo probing of nanoparticle shape-dependent tumor penetration. Angewandte Chemie International Edition, 50(48), 11417–11420.
Zhang, L., Wang, Y., Yang, D., Huang, W., Hao, P., Feng, S., Appelhans, D., Zhang, T., & Zan, X. (2019). Shape effect of nanoparticles on tumor penetration in monolayers versus spheroids. Molecular Pharmaceutics, 16(7), 2902–2911.
You, Y., Hu, H., He, L., & Chen, T. (2015). Differential effects of polymer-surface decoration on drug delivery, cellular retention, and action mechanisms of functionalized mesoporous silica nanoparticles. Chemistry – An Asian Journal, 10(12), 2744–2754.
Figueiredo, P., Sipponen, M. H., Lintinen, K., Correia, A., Kiriazis, A., Yli-Kauhaluoma, J., Österberg, M., George, A., Hirvonen, J., Kostiainen, M. A., & Santos, H. A. (2019). Preparation and characterization of dentin phosphophoryn-derived peptide-functionalized lignin nanoparticles for enhanced cellular uptake. Small, 15(24), 1901427.
Wang, Y., Yin, S., Mei, L., Yang, Y., Xu, S., He, X., Wang, M., Li, M., Zhang, Z., & He, Q. (2020). A dual receptors-targeting and size-switchable “cluster bomb” co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer. Journal of Controlled Release, 321, 71–83.
Hortelão, A. C., Carrascosa, R., Murillo-Cremaes, N., Patiño, T., & Sánchez, S. (2019). Targeting 3D bladder cancer spheroids with urease-powered nanomotors. ACS Nano, 13(1), 429–439.
Fan, R., Chuan, D., Hou, H., Chen, H., Han, B., Zhang, X., Zhou, L., Tong, A., Xu, J., & Guo, G. (2019). Development of a hybrid nanocarrier-recognizing tumor vasculature and penetrating the BBB for glioblastoma multi-targeting therapy. Nanoscale, 11(23), 11285–11304.
Hu, C., Yang, X., Liu, R., Ruan, S., Zhou, Y., Xiao, W., Yu, W., Yang, C., & Gao, H. (2018). Coadministration of iRGD with multistage responsive nanoparticles enhanced tumor targeting and penetration abilities for breast cancer therapy. ACS Applied Materials & Interfaces, 10(26), 22571–22579.
Marino, A., Camponovo, A., Degl’Innocenti, A., Bartolucci, M., Tapeinos, C., Martinelli, C., De Pasquale, D., Santoro, F., Mollo, V., Arai, S., Suzuki, M., Harada, Y., Petretto, A., & Ciofani, G. (2019). Multifunctional temozolomide-loaded lipid superparamagnetic nanovectors: Dual targeting and disintegration of glioblastoma spheroids by synergic chemotherapy and hyperthermia treatment. Nanoscale, 11(44), 21227–21248.
Chariou, P. L., Lee, K. L., Pokorski, J. K., Saidel, G. M., & Steinmetz, N. F. (2016). Diffusion and uptake of tobacco mosaic virus as therapeutic carrier in tumor tissue: Effect of nanoparticle aspect ratio. The Journal of Physical Chemistry B, 120(26), 6120–6129.
Goodman, T. T., Olive, P. L., & Pun, S. H. (2007). Increased nanoparticle penetration in collagenase-treated multicellular spheroids. International Journal of Nanomedicine, 2(2), 265–274.
Zhang, Y., Liu, Y., Gao, X., Li, X., Niu, X., Yuan, Z., & Wang, W. (2019). Near-infrared-light induced nanoparticles with enhanced tumor tissue penetration and intelligent drug release. Acta Biomaterialia, 90, 314–323.
Wang, X., Luo, J., He, L., Cheng, X., Yan, G., Wang, J., & Tang, R. (2018). Hybrid pH-sensitive nanogels surface-functionalized with collagenase for enhanced tumor penetration. Journal of Colloid and Interface Science, 525, 269–281.
Miranda, M. A., Marcato, P. D., Carvalho, I. P. S., Silva, L. B., Ribeiro, D. L., Amaral, R., Swiech, K., Bastos, J. K., Paschoal, J. A. R., dos Reis, R. B., & Bentley, M. V. L. B. (2019). Assessing the cytotoxic potential of glycoalkaloidic extract in nanoparticles against bladder cancer cells. Journal of Pharmacy and Pharmacology, 71(10), 1520–1531.
Ishiguro, S., Cai, S., Uppalapati, D., Turner, K., Zhang, T., Forrest, W. C., Forrest, M. L., & Tamura, M. (2016). Intratracheal administration of hyaluronan-cisplatin conjugate nanoparticles significantly attenuates lung cancer growth in mice. Pharmaceutical Research, 33(10), 2517–2529.
Godugu, C., Patel, A. R., Desai, U., Andey, T., Sams, A., & Singh, M. (2013). AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies. PLoS One, 8(1), e53708.
Affram, K. O., Smith, T., Ofori, E., Krishnan, S., Underwood, P., Trevino, J. G., & Agyare, E. (2020). Cytotoxic effects of gemcitabine-loaded solid lipid nanoparticles in pancreatic cancer cells. Journal of Drug Delivery Science and Technology, 55, 101374.
Leite, P. E. C., Pereira, M. R., Harris, G., Pamies, D., dos Santos, L. M. G., Granjeiro, J. M., Hogberg, H. T., Hartung, T., & Smirnova, L. (2019). Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery. Particle and Fibre Toxicology, 16(1), 22.
Zhou, Z., Liu, J., Huang, J., Rees, T. W., Wang, Y., Wang, H., Li, X., Chao, H., & Stang, P. J. (2019). A self-assembled Ru–Pt metallacage as a lysosome-targeting photosensitizer for 2-photon photodynamic therapy. Proceedings of the National Academy of Sciences, 116(41), 20296–20302.
Ramgolam, K., Lauriol, J., Lalou, C., Lauden, L., Michel, L., de la Grange, P., Khatib, A.-M., Aoudjit, F., Charron, D., Alcaide-Loridan, C., & Al-Daccak, R. (2011). Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS One, 6(4), e18784.
Horman, S. R., Hogan, C., Reyes, K. D., Lo, F., & Antczak, C. (2015). Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell models. Future Medicinal Chemistry, 7(4), 513–525.
Priwitaningrum, D. L., Blondé, J.-B. G., Sridhar, A., van Baarlen, J., Hennink, W. E., Storm, G., Le Gac, S., & Prakash, J. (2016). Tumor stroma-containing 3D spheroid arrays: A tool to study nanoparticle penetration. Journal of Controlled Release, 244, 257–268.
Wang, H.-X., Zuo, Z.-Q., Du, J.-Z., Wang, Y.-C., Sun, R., Cao, Z.-T., Ye, X.-D., Wang, J.-L., Leong, K. W., & Wang, J. (2016). Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines. Nano Today, 11(2), 133–144.
Acknowledgments
T. Bauleth-Ramos acknowledges financial support from Fundação para a Ciência e a Tecnologia (grant no. SFRH/BD/110859/2015). This work was financed by the project NORTE-01-0145-FEDER-000012 by Norte Portugal Regional Operational Programme (NORTE 2020), and COMPETE 2020 – Operacional Programme for Competitiveness and Internationalisation (POCI), under the PORTUGAL 2020 Partnership Agreement, through the (FEDER) Fundo Europeu de Desenvolvimento Regional and by Portuguese funds through (FCT) Fundação para a Ciência e a Tecnologia/Ministério da Ciência, Tecnologia e Ensino Superior in the framework of the project “Institute for Research and Innovation in Health Sciences” UID/BIM/04293/2019.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bauleth-Ramos, T., Sarmento, B. (2021). In Vitro Assays for Nanoparticle—Cancer Cell Interaction Studies. In: Fontana, F., Santos, H.A. (eds) Bio-Nanomedicine for Cancer Therapy. Advances in Experimental Medicine and Biology, vol 1295. Springer, Cham. https://doi.org/10.1007/978-3-030-58174-9_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-58174-9_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58173-2
Online ISBN: 978-3-030-58174-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)